Intra-Cellular Therapies, Inc.

Pharmaceutical company · Bedminster, New Jersey, United States

Intra-Cellular Therapies, Inc. is a pharmaceutical company headquartered in Bedminster, New Jersey, United States. Its earliest recorded incorporation is in 2012. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $60 million sold in a notice filed in 2013.

Profile compiled from public records. Is this your company? Request a correction or update

Intra-Cellular Therapies at a glance

Typepharmaceutical company
HeadquartersBedminster, New Jersey, United States
Earliest incorporation on record2012
SEC industryPharmaceutical Preparations

What does Intra-Cellular Therapies do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2003 to 2016). NIH funding came from the National Institute of Mental Health.

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $60 million sold (2013).

Frequently asked questions about Intra-Cellular Therapies

Where is Intra-Cellular Therapies headquartered?

Intra-Cellular Therapies, Inc. is headquartered in Bedminster, New Jersey, United States.

What does Intra-Cellular Therapies do?

Intra-Cellular Therapies, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Intra-Cellular Therapies founded?

The earliest incorporation on record for Intra-Cellular Therapies, Inc. is in 2012, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.